Literature DB >> 29351427

Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance.

Nicola Aberdein1,2, Robert J Dambrino1, Jussara M do Carmo1, Zhen Wang1, Laura E Mitchell1, Heather A Drummond1, John E Hall1.   

Abstract

Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of leptin receptor signaling and may contribute to leptin resistance in diet-induced obesity. Although PTP1B inhibition has been suggested as a potential weight loss therapy, the role of specific neuronal PTP1B signaling in cardiovascular and metabolic regulation and the importance of sex differences in this regulation are still unclear. In this study, we investigated the impact of proopiomelanocortin (POMC) neuronal PTP1B deficiency in cardiometabolic regulation in male and female mice fed a high-fat diet (HFD). When compared with control mice (PTP1B flox/flox), male and female mice deficient in POMC neuronal PTP1B (PTP1B flox/flox/POMC-Cre) had attenuated body weight gain (males: -18%; females: -16%) and fat mass (males: -33%; female: -29%) in response to HFD. Glucose tolerance was improved by 40%, and liver lipid accumulation was reduced by 40% in PTP1B/POMC-Cre males but not in females. When compared with control mice, deficiency of POMC neuronal PTP1B did not alter mean arterial pressure (MAP) in male or female mice (males: 112 ± 1 vs. 112 ± 1 mmHg in controls; females: 106 ± 3 vs. 109 ± 3 mmHg in controls). Deficiency of POMC neuronal PTP1B also did not alter MAP response to acute stress in males or females compared with control mice (males: Δ32 ± 0 vs. Δ29 ± 4 mmHg; females: Δ22 ± 2 vs. Δ27 ± 4 mmHg). These data demonstrate that POMC-specific PTP1B deficiency improved glucose tolerance and attenuated diet-induced fatty liver only in male mice and attenuated weight gain in males and females but did not enhance the MAP and HR responses to a HFD or to acute stress.

Entities:  

Keywords:  blood pressure; glucose; leptin; lipid; liver; obesity

Mesh:

Substances:

Year:  2017        PMID: 29351427      PMCID: PMC5899251          DOI: 10.1152/ajpregu.00287.2017

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  31 in total

1.  Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhengwei Cai; Shuying Lin; John H Dubinion; John E Hall
Journal:  Hypertension       Date:  2011-03-21       Impact factor: 10.190

2.  The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence.

Authors:  J V Frangioni; P H Beahm; V Shifrin; C A Jost; B G Neel
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

3.  Shp2 signaling in POMC neurons is important for leptin's actions on blood pressure, energy balance, and glucose regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Sabira E Ebaady; Price O Sessums; Ralph S Abraham; Joel K Elmquist; Bradford B Lowell; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-10-22       Impact factor: 3.619

4.  Food intake reductions and increases in energetic responses by hindbrain leptin and melanotan II are enhanced in mice with POMC-specific PTP1B deficiency.

Authors:  Bart C De Jonghe; Matthew R Hayes; Derek J Zimmer; Scott E Kanoski; Harvey J Grill; Kendra K Bence
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

5.  Ventromedial hypothalamus-specific Ptpn1 deletion exacerbates diet-induced obesity in female mice.

Authors:  Franck Chiappini; Karyn J Catalano; Jennifer Lee; Odile D Peroni; Jacqueline Lynch; Abha S Dhaneshwar; Kerry Wellenstein; Alexandra Sontheimer; Benjamin G Neel; Barbara B Kahn
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

6.  Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.

Authors:  Nina Balthasar; Roberto Coppari; Julie McMinn; Shun M Liu; Charlotte E Lee; Vinsee Tang; Christopher D Kenny; Robert A McGovern; Streamson C Chua; Joel K Elmquist; Bradford B Lowell
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

Review 7.  Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.

Authors:  Shlomit Koren; I George Fantus
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-12       Impact factor: 4.690

8.  Protein tyrosine phosphatase 1B and insulin resistance: role of endoplasmic reticulum stress/reactive oxygen species/nuclear factor kappa B axis.

Authors:  Evgeniy Panzhinskiy; Jun Ren; Sreejayan Nair
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.752

Review 9.  Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

10.  A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.

Authors:  Gyun Jee Song; Myungsu Jung; Jong-Heon Kim; Hana Park; Md Habibur Rahman; Sheng Zhang; Zhong-Yin Zhang; Dong Ho Park; Hyun Kook; In-Kyu Lee; Kyoungho Suk
Journal:  J Neuroinflammation       Date:  2016-04-19       Impact factor: 8.322

View more
  9 in total

Review 1.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 2.  The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.

Authors:  Maryam Teimouri; Hossein Hosseini; Zahra ArabSadeghabadi; Reyhaneh Babaei-Khorzoughi; Sattar Gorgani-Firuzjaee; Reza Meshkani
Journal:  J Physiol Biochem       Date:  2022-01-06       Impact factor: 4.158

3.  Melatonin Alleviates PM2.5-Induced Hepatic Steatosis and Metabolic-Associated Fatty Liver Disease in ApoE-/- Mice.

Authors:  Zhou Du; Shuang Liang; Yang Li; Jingyi Zhang; Yang Yu; Qing Xu; Zhiwei Sun; Junchao Duan
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

4.  Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease.

Authors:  Lin Chen; Xiujuan Zhang; Li Zhang; Dongmei Zheng
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-06       Impact factor: 3.168

Review 5.  Obesity, kidney dysfunction, and inflammation: interactions in hypertension.

Authors:  John E Hall; Alan J Mouton; Alexandre A da Silva; Ana C M Omoto; Zhen Wang; Xuan Li; Jussara M do Carmo
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

Review 6.  POMC neuronal heterogeneity in energy balance and beyond: an integrated view.

Authors:  Carmelo Quarta; Marc Claret; Lori M Zeltser; Kevin W Williams; Giles S H Yeo; Matthias H Tschöp; Sabrina Diano; Jens C Brüning; Daniela Cota
Journal:  Nat Metab       Date:  2021-02-25

7.  Chronic High-Fat Diet Exacerbates Sexually Dimorphic Pomctm1/tm1 Mouse Obesity.

Authors:  Kristina Hubbard; Avik Shome; Bo Sun; Beau Pontré; Ailsa McGregor; Kathleen G Mountjoy
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 8.  Nonalcoholic fatty liver disease shows significant sex dimorphism.

Authors:  Xing-Yu Chen; Cong Wang; Yi-Zhou Huang; Li-Li Zhang
Journal:  World J Clin Cases       Date:  2022-02-16       Impact factor: 1.337

Review 9.  Recent advances in neuropeptide-related omics and gene editing: Spotlight on NPY and somatostatin and their roles in growth and food intake of fish.

Authors:  Xiaozheng Yu; Haijun Yan; Wensheng Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.